Protea Biosciences Concludes New Technology License Agreement
LAESI technology identifies viral-infected cells in minutes
10-Sep-2010 -
ProteaBio Europe SAS announced that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules.
Known as Laser Ablation ...
chemicals
chemistry
license agreements
+5